Showing results (131-140 of 150) with videos related to

Sort By:
Pageof 15
Lancet (London, England)|March 9, 2016
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trialJonathan E Rosenberg, Jean Hoffman-Censits, Tom Powles, et al.
European Urology|March 11, 2023
European Association of Urology-American Society of Clinical Oncology Collaborative Guideline on Penile Cancer: 2023 UpdateOscar R Brouwer, Maarten Albersen, Arie Parnham, et al.
Cell Reports. Medicine|July 3, 2025
Epigenetic profiling identifies markers of endocrine resistance and therapeutic options for metastatic castration-resistant prostate cancerTesa M Severson, Emma Minnee, Yanyun Zhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2019
Molecular Characterization of Neuroendocrine-like Bladder CancerJosé Batista da Costa, Ewan A Gibb, Trinity J Bivalacqua, et al.
Cancer Cell|November 22, 2024
Molecular heterogeneity in urothelial carcinoma and determinants of clinical benefit to PD-L1 blockadeHabib Hamidi, Yasin Senbabaoglu, Niha Beig, et al.
BJU International|February 7, 2023
Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomyFrancesco Claps, Maaike W van de Kamp, Roman Mayr, et al.
European Urology|May 19, 2023
Management of Lymph Node-positive Penile Cancer: A Systematic ReviewAshwin Sachdeva, Luke McGuinness, Łukasz Zapala, et al.
International Journal of Cancer|April 20, 2018
Pathogenic and targetable genetic alterations in 70 urachal adenocarcinomasHenning Reis, Kristan E van der Vos, Christian Niedworok, et al.
European Urology|April 10, 2017
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant ChemotherapyRoland Seiler, Hussam Al Deen Ashab, Nicholas Erho, et al.
Science Translational Medicine|November 9, 2018
Enhanced detection of circulating tumor DNA by fragment size analysisFlorent Mouliere, Dineika Chandrananda, Anna M Piskorz, et al.
Pageof 15